Parenting a child with type 1 diabetes: Challenges and the role of social support

Melike Taşdelen Baş1, Hatice Dönmez2, Birsel Molu1

  • 1Selçuk University Akşehir Kadir Yallagöz Health School, Department of Nursing, Konya, Türkiye.

PubMed

Insights

Parents of children with Type 1 diabetes face significant challenges, particularly around hypoglycemia and injections. Strong social support from family and peers can help alleviate these concerns, improving disease management.

Area of Science:

  • Pediatric Endocrinology
  • Psychosocial Aspects of Chronic Illness
  • Family Support Systems

Background:

  • Type 1 diabetes (T1D) is a chronic pediatric condition demanding intensive daily management.
  • Parenting a child with T1D imposes significant emotional and practical burdens.
  • Social support is crucial for parental coping mechanisms in T1D management.

Purpose of the Study:

  • To identify challenges faced by parents of children with T1D.
  • To examine the relationship between these challenges and perceived social support.

Main Methods:

  • Descriptive, cross-sectional study design.
  • Involved parents of children (0-18 years) diagnosed with T1D.
  • Utilized "Challenges Experienced by Parents of Children with Type 1 Diabetes Questionnaire" and "Multidimensional Scale of Perceived Social Support" via face-to-face surveys.

Main Results:

  • Nocturnal hypoglycemia and fear of hypoglycemia were the primary parental concerns (95.8% and 94%, respectively).
  • Fear of injections correlated with family support (p=.013); preventing hypoglycemia correlated with peer support (p=.035).
  • Higher perceived social support was linked to reduced general disease management concerns (p=.034).

Conclusions:

  • Parents of children with T1D experience substantial anxiety.
  • Family, peer, and social network support offer a protective effect against T1D management challenges.
  • Recommendations include strengthening social support and expanding family diabetes education programs.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
386
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262